Taken together with prior evidence of strong associations between tau deposition and clinical presentation of AD [16], it is likely that elevated quantity of, and vulnerability to, tau pathology in women, may contribute to their more precipitous progression of cognitive decline [17]. The gene discussed is MAPT; the disease is Mental deterioration.